202 related articles for article (PubMed ID: 35849710)
1. Intraosseous delivery of platelet-targeted factor VIII lentiviral vector in humanized NBSGW mice.
Joo JH; Wang X; Singh S; Chen CY; Li C; Adair JE; Kiem HP; Rawlings DJ; Miao CH
Blood Adv; 2022 Oct; 6(19):5556-5569. PubMed ID: 35849710
[TBL] [Abstract][Full Text] [Related]
2. Enhancing therapeutic efficacy of in vivo platelet-targeted gene therapy in hemophilia A mice.
Wang X; Fu RY; Li C; Chen CY; Firrman J; Konkle BA; Zhang J; Li L; Xiao W; Poncz M; Miao CH
Blood Adv; 2020 Nov; 4(22):5722-5734. PubMed ID: 33216891
[TBL] [Abstract][Full Text] [Related]
3. Hemophilia A gene therapy via intraosseous delivery of factor VIII-lentiviral vectors.
Miao CH
Thromb J; 2016; 14(Suppl 1):41. PubMed ID: 27766066
[TBL] [Abstract][Full Text] [Related]
4. Intraosseous delivery of lentiviral vectors targeting factor VIII expression in platelets corrects murine hemophilia A.
Wang X; Shin SC; Chiang AF; Khan I; Pan D; Rawlings DJ; Miao CH
Mol Ther; 2015 Apr; 23(4):617-26. PubMed ID: 25655313
[TBL] [Abstract][Full Text] [Related]
5. Preclinical Development of a Hematopoietic Stem and Progenitor Cell Bioengineered Factor VIII Lentiviral Vector Gene Therapy for Hemophilia A.
Doering CB; Denning G; Shields JE; Fine EJ; Parker ET; Srivastava A; Lollar P; Spencer HT
Hum Gene Ther; 2018 Oct; 29(10):1183-1201. PubMed ID: 30160169
[TBL] [Abstract][Full Text] [Related]
6. Transduction of modified factor VIII gene improves lentiviral gene therapy efficacy for hemophilia A.
Gong J; Chung TH; Zheng J; Zheng H; Chang LJ
J Biol Chem; 2021 Dec; 297(6):101397. PubMed ID: 34774524
[TBL] [Abstract][Full Text] [Related]
7. The impact of GPIbα on platelet-targeted FVIII gene therapy in hemophilia A mice with pre-existing anti-FVIII immunity.
Chen J; Schroeder JA; Luo X; Montgomery RR; Shi Q
J Thromb Haemost; 2019 Mar; 17(3):449-459. PubMed ID: 30609275
[TBL] [Abstract][Full Text] [Related]
8. Improved intravenous lentiviral gene therapy based on endothelial-specific promoter-driven factor VIII expression for hemophilia A.
Gong J; Yang R; Zhou M; Chang LJ
Mol Med; 2023 Jun; 29(1):74. PubMed ID: 37308845
[TBL] [Abstract][Full Text] [Related]
9. FVIII expression by its native promoter sustains long-term correction avoiding immune response in hemophilic mice.
Merlin S; Famà R; Borroni E; Zanolini D; Bruscaggin V; Zucchelli S; Follenzi A
Blood Adv; 2019 Mar; 3(5):825-838. PubMed ID: 30862611
[TBL] [Abstract][Full Text] [Related]
10. Platelet gene therapy corrects the hemophilic phenotype in immunocompromised hemophilia A mice transplanted with genetically manipulated human cord blood stem cells.
Shi Q; Kuether EL; Chen Y; Schroeder JA; Fahs SA; Montgomery RR
Blood; 2014 Jan; 123(3):395-403. PubMed ID: 24269957
[TBL] [Abstract][Full Text] [Related]
11. Efficient production of human FVIII in hemophilic mice using lentiviral vectors.
Kootstra NA; Matsumura R; Verma IM
Mol Ther; 2003 May; 7(5 Pt 1):623-31. PubMed ID: 12718905
[TBL] [Abstract][Full Text] [Related]
12. Ectopic Expression of FVIII in HPCs and MSCs Derived from hiPSCs with Site-Specific Integration of
Zhao J; Zhou M; Wang Z; Wu L; Hu Z; Liang D
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054807
[TBL] [Abstract][Full Text] [Related]
13. CD14+/CD31+ monocytes expanded by UM171 correct hemophilia A in zebrafish upon lentiviral gene transfer of factor VIII.
Elnaggar M; Al-Mohannadi A; Hasan W; Abdelrahman D; Al-Kubaisi MJ; Pavlovski I; Gentilcore G; Sathappan A; Kizhakayil D; Ali AI; Mohan S; Olagunju D; Cugno C; Grivel JC; Borsotti C; Follenzi A; Da'as SI; Deola S
Blood Adv; 2023 Mar; 7(5):697-711. PubMed ID: 36477543
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo gene therapy for hemophilia A that enhances safe delivery and sustained in vivo factor VIII expression from lentivirally engineered endothelial progenitors.
Matsui H; Shibata M; Brown B; Labelle A; Hegadorn C; Andrews C; Hebbel RP; Galipeau J; Hough C; Lillicrap D
Stem Cells; 2007 Oct; 25(10):2660-9. PubMed ID: 17615271
[TBL] [Abstract][Full Text] [Related]
15. Lentivirus-mediated platelet-derived factor VIII gene therapy in murine haemophilia A.
Shi Q; Wilcox DA; Fahs SA; Fang J; Johnson BD; DU LM; Desai D; Montgomery RR
J Thromb Haemost; 2007 Feb; 5(2):352-61. PubMed ID: 17269937
[TBL] [Abstract][Full Text] [Related]
16. Efficient expression of a transgene in platelets using simian immunodeficiency virus-based vector harboring glycoprotein Ibalpha promoter: in vivo model for platelet-targeting gene therapy.
Ohmori T; Mimuro J; Takano K; Madoiwa S; Kashiwakura Y; Ishiwata A; Niimura M; Mitomo K; Tabata T; Hasegawa M; Ozawa K; Sakata Y
FASEB J; 2006 Jul; 20(9):1522-4. PubMed ID: 16723382
[TBL] [Abstract][Full Text] [Related]
17. Directed engineering of a high-expression chimeric transgene as a strategy for gene therapy of hemophilia A.
Doering CB; Denning G; Dooriss K; Gangadharan B; Johnston JM; Kerstann KW; McCarty DA; Spencer HT
Mol Ther; 2009 Jul; 17(7):1145-54. PubMed ID: 19259064
[TBL] [Abstract][Full Text] [Related]
18. Altered bioavailability of platelet-derived factor VIII during thrombocytosis reverses phenotypic efficacy in haemophilic mice.
Damon AL; Scudder LE; Gnatenko DV; Sitaraman V; Hearing P; Jesty J; Bahou WF
Thromb Haemost; 2008 Dec; 100(6):1111-22. PubMed ID: 19132238
[TBL] [Abstract][Full Text] [Related]
19. Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies.
Shi Q; Wilcox DA; Fahs SA; Weiler H; Wells CW; Cooley BC; Desai D; Morateck PA; Gorski J; Montgomery RR
J Clin Invest; 2006 Jul; 116(7):1974-82. PubMed ID: 16823491
[TBL] [Abstract][Full Text] [Related]
20. Generation of an optimized lentiviral vector encoding a high-expression factor VIII transgene for gene therapy of hemophilia A.
Johnston JM; Denning G; Doering CB; Spencer HT
Gene Ther; 2013 Jun; 20(6):607-15. PubMed ID: 22996197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
